Who We Are
Caplin Steriles USA Inc. is the next courageous step in our parent company’s storied history of taking the road less travelled to fulfil the healthcare needs of the underserved.
We are a wholly owned subsidiary of Caplin Steriles Ltd India, operating as their sales and marketing arm focused on the U.S. market. Caplin Steriles is an R&D driven company focused on the development and manufacturing of high quality Injectables and Ophthalmic products for Regulated Markets.
The Caplin Approach
At Caplin, there is absolutely no compromise on the product quality, innovation, and timely availability of medicines. Over the years, the Company has been aggressively expanding manufacturing, product innovation and R&D capabilities. There has been a consistent and conscious effort to diversify the product mix and expand the Company’s product portfolio. The latest move to digitalize and automate multiple functions of the company would help accelerate the company’s next trajectory of growth.
Our Recent Launches
The company principally operates through three primary segments — Construction Industries, Resource Industries and Energy & Transportation — and provides financing and related services through its Financial Products segment.
Glycopyrrolate Injection, USP
Phenylephrine HCL Injection,USP
Sodium nitroprusside Injection
Verapamil hydrochloride Injection, USP
Upcoming Events
April 19-20, 2024
Test Event Name and Location
April 19-20, 2024
Test Event Name and Location
April 18-21, 2024
Test Event Name and Location